Yaron Carmi

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Venues

eLife

Nature medicine

Proceedings of the National Academy of Sciences of the United States of America

Nature biotechnology

Tel Aviv University

Stanford University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tel Aviv University Sep 01 2016

Israel

Senior lecturer :: Pathology

Education History

Stanford University School of Medicine Sep 01 2011 - Jul 15 2016

United States

PHD :: Immunology

Ben-Gurion University of the Negev Oct 31 2006 - Aug 20 2011

Israel

PHD :: Immunology

Ben-Gurion University of the Negev Oct 01 2004 - Oct 30 2006

Israel

MSC :: Immunology

Publications

Leen Farhat-Younis, Manho Na, Amichai Zarfin, Aseel Khateeb, Nadine Santana-Magal, Alon Richter, Amit Gutwillig, Diana Rasoulouniriana, Annette Gleiberman, Lir Beck, Tamar Giger, Avraham Ashkenazi, Adi Barzel, Peleg Rider, Yaron Carmi
Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. eLife 12 (2024)
Leen Farhat-Younis, Manho Na, Amichai Zarfin, Aseel Khateeb, Nadine Santana-Magal, Alon Richter, Amit Gutwillig, Diana Rasoulouniriana, Annette Gleiberman, Lir Beck, Tamar Giger, Avraham Ashkenazi, Adi Barzel, Peleg Rider, Yaron Carmi
Correction: Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. eLife 13 (2024)
Leen Farhat-Younis, Manho Na, Amichai Zarfin, Aseel Khateeb, Nadine Santana-Magal, Alon Richter, Amit Gutwillig, Diana Rasoulouniriana, Annette Gleiberman, Lir Beck, Tamar Giger, Avraham Ashkenazi, Adi Barzel, Peleg Rider, Yaron Carmi
Correction: Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. eLife 13 (2024)
Breanna M Allen, Kamir J Hiam-Galvez, Cassandra E Burnett, Anthony Venida, Rachel DeBarge, Iliana Tenvooren, Diana M Marquez, Nam Woo Cho, Yaron Carmi, Matthew H Spitzer
Author Correction: Systemic dysfunction and plasticity of the immune macroenvironment in cancer models. Nature medicine (2024)
Leen Farhat-Younis, Manho Na, Amichai Zarfin, Aseel Khateeb, Nadine Santana-Magal, Alon Richter, Amit Gutwillig, Diana Rasoulouniriana, Annette Gleiberman, Lir Beck, Tamar Giger, Avraham Ashkenazi, Adi Barzel, Peleg Rider, Yaron Carmi
Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. eLife 12 (2024)
Leen Farhat-Younis, Manho Na, Amichai Zarfin, Aseel Khateeb, Nadine Santana-Magal, Alon Richter, Amit Gutwillig, Diana Rasoulouniriana, Annette Gleiberman, Lir Beck, Tamar Giger, Avraham Ashkenazi, Adi Barzel, Peleg Rider, Yaron Carmi
Correction: Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. eLife 13 (2024)
Diana Rasoulouniriana, Nadine Santana-Magal, Amit Gutwillig, Leen Farhat-Younis, Lior Tal, Sarah Amar, Michael Milyavsky, Siva Sai Naga Anurag Muddineni, Neta Solomon, Hana Shpilt, Shahar Dotan, Noam Pilpel, Claudia Waskow, Meora Feinmesser, Peleg Rider, Yaron Carmi
T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors. Cancer immunology research (2023)
Amit Gutwillig, Nadine Santana-Magal, Leen Farhat-Younis, Diana Rasoulouniriana, Asaf Madi, Chen Luxenburg, Jonathan Cohen, Krishnanand Padmanabhan, Noam Shomron, Guy Shapira, Annette Gleiberman, Roma Parikh, Carmit Levy, Meora Feinmesser, Dov Hershkovitz, Valentina Zemser-Werner, Oran Zlotnik, Sanne Kroon, Wolf-Dietrich Hardt, Reno Debets, Nathan Edward Reticker-Flynn, Peleg Rider, Yaron Carmi
Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy. eLife 11 (2022)
Alessio David Nahmad, Cicera R Lazzarotto, Natalie Zelikson, Talia Kustin, Mary Tenuta, Deli Huang, Inbal Reuveni, Daniel Nataf, Yuval Raviv, Miriam Horovitz-Fried, Iris Dotan, Yaron Carmi, Rina Rosin-Arbesfeld, David Nemazee, James E Voss, Adi Stern, Shengdar Q Tsai, Adi Barzel
In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice. Nature biotechnology 40 (8) (2022)
Alessio David Nahmad, Yuval Raviv, Miriam Horovitz-Fried, Ilan Sofer, Tal Akriv, Daniel Nataf, Iris Dotan, Yaron Carmi, David Burstein, Yariv Wine, Itai Benhar, Adi Barzel
Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion. Nature communications 11 (1) (2020)
Breanna M Allen, Kamir J Hiam-Galvez, Cassandra E Burnett, Anthony Venida, Rachel DeBarge, Iliana Tenvooren, Diana M Marquez, Nam Woo Cho, Yaron Carmi, Matthew H Spitzer
Systemic dysfunction and plasticity of the immune macroenvironment in cancer models. Nature medicine 26 (7) (2020)
Shelley E Ackerman, Cecelia I Pearson, Joshua D Gregorio, Joseph C Gonzalez, Justin A Kenkel, Felix J Hartmann, Angela Luo, Po Y Ho, Heidi LeBlanc, Lisa K Blum, Samuel C Kimmey, Andrew Luo, Murray L Nguyen, Jason C Paik, Lauren Y Sheu, Benjamin Ackerman, Arthur Lee, Hai Li, Jennifer Melrose, Richard P Laura, Vishnu C Ramani, Karla A Henning, David Y Jackson, Brian S Safina, Grant Yonehiro, Bruce H Devens, Yaron Carmi, Steven J Chapin, Sean C Bendall, Marcin Kowanetz, David Dornan, Edgar G Engleman, Michael N Alonso
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity. Nature cancer 2 (1) (2020)
Irena Kaplanov, Yaron Carmi, Rachel Kornetsky, Avishai Shemesh, Galina V Shurin, Michael R Shurin, Charles A Dinarello, Elena Voronov, Ron N Apte
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proceedings of the National Academy of Sciences of the United States of America 116 (4) (2018)
Hong Zhang, Josh D Gregorio, Toru Iwahori, Xiangyue Zhang, Okmi Choi, Lorna L Tolentino, Tyler Prestwood, Yaron Carmi, Edgar G Engleman
A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 114 (8) (2017)

Yaron Carmi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yaron Carmi